ACCESSION: MSBNK-SMB_Measured-HSA032P0387001
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 34
COMMENT: RAW_SPEC {'RA11-pos_7276': {'bp': 1247.0, 'sum': 1502.0}, 'HC22-pos_7352': {'bp': 1003.0, 'sum': 1360.0}, 'QC1-pos_6967': {'bp': 974.0, 'sum': 1280.0}, 'RA16-pos_6933': {'bp': 970.0, 'sum': 1021.0}, 'RA19-pos_7482': {'bp': 842.0, 'sum': 943.0}, 'RA26-pos_7011': {'bp': 819.0, 'sum': 870.0}, 'RA13-pos_7431': {'bp': 814.0, 'sum': 967.0}, 'HC6-pos_7468': {'bp': 721.0, 'sum': 1280.0}, 'RA18-pos_7385': {'bp': 626.0, 'sum': 983.0}, 'HC17-pos_7261': {'bp': 624.0, 'sum': 777.0}, 'RA9-pos_7019': {'bp': 612.0, 'sum': 813.0}, 'HC22-pos_7435': {'bp': 545.0, 'sum': 800.0}, 'HC1-pos_7606': {'bp': 489.0, 'sum': 591.0}, 'RA26-pos_7130': {'bp': 439.0, 'sum': 539.0}, 'RA1-pos_8005': {'bp': 422.0, 'sum': 727.0}, 'HC1-pos_7776': {'bp': 390.0, 'sum': 492.0}, 'HC26-pos_7769': {'bp': 384.0, 'sum': 486.0}, 'HC9-pos_7424': {'bp': 378.0, 'sum': 529.0}, 'HC13-pos_7674': {'bp': 355.0, 'sum': 457.0}, 'RA9-pos_7047': {'bp': 349.0, 'sum': 451.0}, 'HC12-pos_7600': {'bp': 334.0, 'sum': 385.0}, 'HC6-pos_7656': {'bp': 326.0, 'sum': 377.0}, 'RA4-pos_7399': {'bp': 305.0, 'sum': 509.0}, 'HC17-pos_7277': {'bp': 304.0, 'sum': 355.0}, 'HC22-pos_7574': {'bp': 292.0, 'sum': 447.0}, 'HC2-pos_7657': {'bp': 288.0, 'sum': 390.0}, 'HC9-pos_7548': {'bp': 257.0, 'sum': 282.0}, 'HC18-pos_7183': {'bp': 254.0, 'sum': 458.0}, 'RA7-pos_7338': {'bp': 248.0, 'sum': 429.0}, 'HC14-pos_7418': {'bp': 246.0, 'sum': 297.0}, 'HC12-pos_7778': {'bp': 203.0, 'sum': 254.0}, 'HC12-pos_7803': {'bp': 203.0, 'sum': 254.0}, 'HC23-pos_7350': {'bp': 203.0, 'sum': 254.0}, 'HC24-pos_7312': {'bp': 203.0, 'sum': 254.0}}
COMMENT: RETENTION_TIME_STDEV 0.100
COMMENT: PRECURSOR_M/Z_RAW 387.251448
COMMENT: PRECURSOR_M/Z_STDEV 0.001332
COMMENT: PRECURSOR_IN_MS1 mz 387.253512; int 36.832; delta(ppm) 11.397643
COMMENT: PROPOSED_CHARGE_STATE +1; mz 388.255178; int 17.576; cor 0.640
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 13.344; C17H38O9; [M+H]+; delta(ppm) -13.343813
COMMENT: PROPOSED_MF SevenGoldenRules 10.154; C21H40O2P2; [M+H]+; delta(ppm) -10.154139
COMMENT: PROPOSED_MF SevenGoldenRules 5.877; C23H35N2OP; [M+H]+; delta(ppm) -5.877077
COMMENT: PROPOSED_MF SevenGoldenRules 1.600; C25H30N4; [M+H]+; delta(ppm) -1.600015
COMMENT: PROPOSED_MF SevenGoldenRules 0.261; C16H40N2O4P2; [M+H]+; delta(ppm) 0.261491
COMMENT: PROPOSED_MF SevenGoldenRules 1.862; C24H34O4; [M+H]+; delta(ppm) 1.861506
COMMENT: PROPOSED_MF SevenGoldenRules 4.539; C18H35N4O3P; [M+H]+; delta(ppm) 4.538553
COMMENT: PROPOSED_MF SevenGoldenRules 8.000; C17H39O7P; [M+H]+; delta(ppm) 8.000074
COMMENT: PROPOSED_MF SevenGoldenRules 12.277; C19H34N2O6; [M+H]+; delta(ppm) 12.277136
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 16.000; QEEBRPGZBVVINN-UHFFFAOYSA-N; C24H34O4; Bufalin
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 6.000; QEEBRPGZBVVINN-BMPKRDENSA-N; C24H34O4; Massbank:PR303622 Bufalin
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; PSGAAPLEWMOORI-PEINSRQWSA-N; C24H34O4; Massbank:AU281301 MedroxyprogesteroneacetateMedroxyprogesterone acetate[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
COMMENT: CONFIDENCE Level 5: Exact mass of interest 387.253705; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.864
MS$FOCUSED_ION: PRECURSOR_M/Z 387.253705
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-0009000000-5463a980a5618f724ea1
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  387.2556697 999.0000 ? 387.258020 10.3059 0.00 1.0000 34
PK$NUM_PEAK: 1
PK$PEAK: m/z int. rel.int.
  387.255670 999.00 999
//
